Skip to search.
 FTSE 100 Up 0.70%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
21.00 Up 0.01(0.05%) 19:45
Prev Close:20.99
Open:21.10
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.13884
Next Earnings Date:N/A
Day's Range:20.94 - 21.10
52wk Range:18.45 - 22.98
Volume:1,030
Avg Vol (3m):20,275
Market Cap:102.02b
P/E (ttm):115.38
EPS (ttm):0.18
Div & Yield:1.10 (5.33%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.23
P/S (ttm):2.88
Ex-Dividend Date:12-May-16

Analysts

Annual EPS Est (Dec-16) :88.62
Quarterly EPS Est (Jun-16) :20.55
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback